DESTINEY MALPASS: Open Payments
NPI 1023601853 · NORTH CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,069 in 39 payments from 13 companies in 2025. Trend: 2023 $813 · 2024 $841 · 2025 $1,069
Food & beverage: $1,069
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 4 | $320 |
| Regeneron Healthcare Solutions, Inc. | 7 | $147 |
| GENZYME CORPORATION | 3 | $112 |
| Janssen Biotech, Inc. | 5 | $88 |
| Amgen Inc. | 3 | $79 |
| ABBVIE INC. | 4 | $75 |
| Incyte Corporation | 3 | $55 |
| Galderma Laboratories, L.P. | 3 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Organon LLC | 2 | $32 |
Products named: Zoryve, DUPIXENT, TREMFYA, OTEZLA, OPZELURA, LIBTAYO, SKYRIZI, NEMLUVIO.
Industry payments across SC — which companies pay providers there.
